This deviation is due to the fact that the process personnel used the unsupplied verification document number, resulting in the duplication of the verification document number of atorvastatin calcium with that of fluvastatin sodium and capreomycin sulfate concentrate, which belongs to the error in the document and has no effect on the verification result of atorvastatin calcium, but the duplication of the document number may cause the risk of document confusion, so corresponding measures should be taken. See d-tz-api-02at-21001-r for details.<br>
正在翻译中..